Specialty pharmacists can help patients with cancer weigh the benefits and risks of GLP-1 receptor agonists as use expands and new evidence emerges.
News|Articles|August 4, 2026
Cervical Cancer Screening and HPV Self-Collection: What Pharmacists Want Patients to Know
Fact checked by: Laly Havern, PharmD, MS, BCACP
FDA-cleared HPV self-collection kits like Teal Wand expand cervical cancer screening; pharmacists support follow-up, HPV education, and Gardasil.
Advertisement
Advertisement
Cervical cancer is one of the most preventable cancers—and yet screening gaps persist. The recent expansion of HPV self-collection options, including an FDA-cleared at-home kit and updated federal guidelines, is the most significant shift in cervical cancer screening in years. Pharmacists are positioned to play a meaningful role in patient education and access.
Related to this article
Early metformin may curb insulin starts in gestational diabetes, while a separate analysis ties a history of the condition to advanced CKM syndrome.
A community oncology pharmacist explains how seeing patients across the course of their diagnosis builds trust and why accessibility remains the field’s biggest challenge despite advances in AI.
Adding the IL-15 agonist to frontline BCG improved responses in carcinoma in situ without new safety signals; full data are expected at an upcoming congress.
Getting patients vaccinated matters more than which COVID-19 vaccine they receive, says Jodi Longueil, PharmD.
The new agreement lets Hims & Hers patients obtain FDA-approved tirzepatide and orforglipron at Lilly’s self-pay prices.
The approval is supported by findings from the phase 3 OCEANIC-STROKE trial.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Advertisement
Advertisement